Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos

Detalhes bibliográficos
Autor(a) principal: Sperotto, Vitor da Rocha
Data de Publicação: 2021
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações do UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/24291
Resumo: Alchlorophilic algae of the genus Prototheca are disease-causing agents in humans and animals. The species Prototheca zopfii (genotype 2), with recent reclassification suggested for P. bovis, is cited by several authors as the most pathogenic species for animals, mainly in the form of bovine mastitis. Infections are difficult to control due to the high resistance capacity of the agent, causing damage to the producer and risk to human health. In the search for alternatives to control animal prototecosis, in this study several drugs of different natures were tested. In this context, the objective of this work was to determine the minimum inhibitory concentration in vitro of antibacterial and antifungal, essential oils, monoterpenes, terpenes and antimicrobial peptides, against P. zopfii (genotype 2) isolates. The testing methodology was broth microdilution, according to CLSI document M27-A3. To carry out the tests, Prototheca spp. isolates were obtained from milk samples, from rural properties in the northwest region, in the State of Rio Grande do Sul. The agent was identified by colony morphology observation technique, in culture and sporangia micromorphology, with visualization of the presence of endosporulation. For species identification, the genotype-specific PCR 18S rDNA assay was used. Thirty-two isolates of Prototheca spp. were found, based on genetic analysis, all isolates were characterized as P. zopfii (genotype 2) being a 450 bp fragment from the internal amplification control and specific amplicon of genotype 2 (165 bp), detectable for all of them. In the tests, resistance to all antibacterial drugs and essential oils, monoterpenes and terpenes with almost absent inhibitory activity, were observed. Among antifungals, amphotericin B (MIC 0,5 to 32 μg/mL; geometric mean: 4,0 μg/mL) and terbinafine (MIC 0,5 to 128 μg/mL; geometric mean: 3,1 μg/mL) were the ones that stood out as well as ketoconazole and itraconazole. Antimicrobial peptides are a new class of drugs with antimicrobial activity, where the highlights were for pexiganan with MIC range from 5,0 to 10 μg/mL, in addition to producing algaecide effect with 5,0 to 20 μg/mL. The MIC produced by h-Lf1-11 was 10 to 80 μg/mL, whereas LL-37 had MIC range from 20 to 80 μg/mL and 40 to 160 μg/mL was the MIC of cecropin B. In general, the results showed the presence of the agent in one of the most important milk-producing regions in Brazil, as well as new drug options against P. zopfii (genotype 2).
id UFSM_a72b8286d6cca36bb1da44ff222ac2ab
oai_identifier_str oai:repositorio.ufsm.br:1/24291
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2022-05-05T17:22:28Z2022-05-05T17:22:28Z2021-03-19http://repositorio.ufsm.br/handle/1/24291Alchlorophilic algae of the genus Prototheca are disease-causing agents in humans and animals. The species Prototheca zopfii (genotype 2), with recent reclassification suggested for P. bovis, is cited by several authors as the most pathogenic species for animals, mainly in the form of bovine mastitis. Infections are difficult to control due to the high resistance capacity of the agent, causing damage to the producer and risk to human health. In the search for alternatives to control animal prototecosis, in this study several drugs of different natures were tested. In this context, the objective of this work was to determine the minimum inhibitory concentration in vitro of antibacterial and antifungal, essential oils, monoterpenes, terpenes and antimicrobial peptides, against P. zopfii (genotype 2) isolates. The testing methodology was broth microdilution, according to CLSI document M27-A3. To carry out the tests, Prototheca spp. isolates were obtained from milk samples, from rural properties in the northwest region, in the State of Rio Grande do Sul. The agent was identified by colony morphology observation technique, in culture and sporangia micromorphology, with visualization of the presence of endosporulation. For species identification, the genotype-specific PCR 18S rDNA assay was used. Thirty-two isolates of Prototheca spp. were found, based on genetic analysis, all isolates were characterized as P. zopfii (genotype 2) being a 450 bp fragment from the internal amplification control and specific amplicon of genotype 2 (165 bp), detectable for all of them. In the tests, resistance to all antibacterial drugs and essential oils, monoterpenes and terpenes with almost absent inhibitory activity, were observed. Among antifungals, amphotericin B (MIC 0,5 to 32 μg/mL; geometric mean: 4,0 μg/mL) and terbinafine (MIC 0,5 to 128 μg/mL; geometric mean: 3,1 μg/mL) were the ones that stood out as well as ketoconazole and itraconazole. Antimicrobial peptides are a new class of drugs with antimicrobial activity, where the highlights were for pexiganan with MIC range from 5,0 to 10 μg/mL, in addition to producing algaecide effect with 5,0 to 20 μg/mL. The MIC produced by h-Lf1-11 was 10 to 80 μg/mL, whereas LL-37 had MIC range from 20 to 80 μg/mL and 40 to 160 μg/mL was the MIC of cecropin B. In general, the results showed the presence of the agent in one of the most important milk-producing regions in Brazil, as well as new drug options against P. zopfii (genotype 2).Algas aclorofiladas do gênero Prototheca são agentes causadores de doenças em humanos e animais. A espécie Prototheca zopfii (genótipo 2), com recente reclassificação sugerida para P. bovis, é citada por diversos autores como a espécie mais patogênica para os animais, principalmente na forma de mastites bovinas. As infecções são de difícil controle devido à alta capacidade de resistência do agente, determinando prejuízos ao produtor e risco a saúde humana. Na busca de alternativas para o controle da prototecose animal, neste estudo foram testados diversos fármacos de diferentes naturezas. Neste contexto o objetivo deste trabalho foi determinar a concentração inibitória mínima in vitro de antibacterianos, antifúngicos, óleos essenciais, monoterpenos, terpenos e peptídeos antimicrobianos, contra isolados de P. spp. A metodologia dos testes foi a microdiluição em caldo, de acordo com o documento M27-A3 / CLSI. Para realização dos testes foram obtidos isolados de P. spp., a partir de amostras de leite, de propriedades rurais da região noroeste, do Estado do Rio Grande do Sul. A identificação do agente foi por técnica de observação de morfologia de colônia, em cultura e micromorfologia de esporângios, com a visualização da presença de endosporulação. Para identificação das espécies foi utilizada o ensaio de PCR 18S rDNA específico do genótipo. Foram encontrados 32 isolados de Prototheca spp., com base em análises genéticas, todos os isolados foram caracterizados como P. zopfii (genótipo 2) sendo fragmento de 450 pb do controle de amplificação interna e amplicon específico do genótipo 2 (165 pb), detectável para todos eles. Nos testes foram observadas resistência a todos os medicamentos antibacterianos e óleos essenciais, os monoterpenos e terpenos com atividade inibitória quase ausente. Entre os antifúngicos a anfotericina B (CIM 0,5 a 32 μg/mL; média geométrica: 4,0 μg/mL) e a terbinafina (CIM 0,5 a 128 μg/mL; média geométrica: 3,1 μg/mL) foram os que mais se destacaram assim como o cetoconazol e itraconazol. Os peptídeos antimicrobianos são uma nova classe de fármacos com atividade antimicrobiana, onde os destaques foram para o pexiganan com CIM variando de 5,0 a 10 μg/mL, além de produzir efeito algicida com 5,0 a 20 μg/mL. A CIM do h-Lf1-11 foi de 10 a 80 μg/mL, já o LL-37 teve CIM variando de 20 a 80 μg/mL, e 40 a 160 μg/mL foi o CIM do cecropin B. De maneira geral os resultados mostraram a presença do agente em uma das mais importantes regiões produtoras de leite do Brasil, assim como novas opções de fármacos contra P. zopfii (genótipo 2).Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessAlgaZoonoseMastite bovinaPeptídeos antimicrobianosTerbinafinaAlgaeZoonosisBovine mastitisAntimicrobial peptidesTerbinafineCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIASuscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianosIn vitro suscetibility of Prototheca spp., isolated from bovine milk, to essential oils, peptides and antimicrobial drugsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisSanturio, Janio Moraishttp://lattes.cnpq.br/6316012260769979Loreto, Érico Silva deBotton, Sônia de AvilaZanette, Régis AdrielTondolo, Juliana Simoni Moraeshttp://lattes.cnpq.br/4356175197731786Sperotto, Vitor da Rocha20100000000060060060060060060060006a1b29c-fde0-4a69-8097-2a9d6a9d9649fab5fcf3-a5e5-4941-849e-7fa63be0ae7cbee3850b-1736-40d6-af3c-3ab7d978f802860bd8db-e3f1-4b8e-bb3e-f1c8f0b143069f4b7354-7051-4bdf-a038-0f46d7f9740ca2383e43-82f7-4794-89eb-3a535a2d43careponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALTES_PPGFARMACOLOGIA_2021_SPEROTTO_VITOR.pdfTES_PPGFARMACOLOGIA_2021_SPEROTTO_VITOR.pdfTese de Doutoradoapplication/pdf1554071http://repositorio.ufsm.br/bitstream/1/24291/1/TES_PPGFARMACOLOGIA_2021_SPEROTTO_VITOR.pdfc7c4741024948315802bee089f7164ceMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/24291/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/24291/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD531/242912022-05-05 14:22:28.632oai:repositorio.ufsm.br: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 Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-05-05T17:22:28Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
dc.title.alternative.eng.fl_str_mv In vitro suscetibility of Prototheca spp., isolated from bovine milk, to essential oils, peptides and antimicrobial drugs
title Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
spellingShingle Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
Sperotto, Vitor da Rocha
Alga
Zoonose
Mastite bovina
Peptídeos antimicrobianos
Terbinafina
Algae
Zoonosis
Bovine mastitis
Antimicrobial peptides
Terbinafine
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
title_full Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
title_fullStr Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
title_full_unstemmed Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
title_sort Suscetibilidade in vitro de Prototheca spp., isoladas de leite bovino, aos óleos essenciais, aos peptídeos e fármacos antimicrobianos
author Sperotto, Vitor da Rocha
author_facet Sperotto, Vitor da Rocha
author_role author
dc.contributor.advisor1.fl_str_mv Santurio, Janio Morais
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6316012260769979
dc.contributor.referee1.fl_str_mv Loreto, Érico Silva de
dc.contributor.referee2.fl_str_mv Botton, Sônia de Avila
dc.contributor.referee3.fl_str_mv Zanette, Régis Adriel
dc.contributor.referee4.fl_str_mv Tondolo, Juliana Simoni Moraes
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/4356175197731786
dc.contributor.author.fl_str_mv Sperotto, Vitor da Rocha
contributor_str_mv Santurio, Janio Morais
Loreto, Érico Silva de
Botton, Sônia de Avila
Zanette, Régis Adriel
Tondolo, Juliana Simoni Moraes
dc.subject.por.fl_str_mv Alga
Zoonose
Mastite bovina
Peptídeos antimicrobianos
Terbinafina
topic Alga
Zoonose
Mastite bovina
Peptídeos antimicrobianos
Terbinafina
Algae
Zoonosis
Bovine mastitis
Antimicrobial peptides
Terbinafine
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.eng.fl_str_mv Algae
Zoonosis
Bovine mastitis
Antimicrobial peptides
Terbinafine
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Alchlorophilic algae of the genus Prototheca are disease-causing agents in humans and animals. The species Prototheca zopfii (genotype 2), with recent reclassification suggested for P. bovis, is cited by several authors as the most pathogenic species for animals, mainly in the form of bovine mastitis. Infections are difficult to control due to the high resistance capacity of the agent, causing damage to the producer and risk to human health. In the search for alternatives to control animal prototecosis, in this study several drugs of different natures were tested. In this context, the objective of this work was to determine the minimum inhibitory concentration in vitro of antibacterial and antifungal, essential oils, monoterpenes, terpenes and antimicrobial peptides, against P. zopfii (genotype 2) isolates. The testing methodology was broth microdilution, according to CLSI document M27-A3. To carry out the tests, Prototheca spp. isolates were obtained from milk samples, from rural properties in the northwest region, in the State of Rio Grande do Sul. The agent was identified by colony morphology observation technique, in culture and sporangia micromorphology, with visualization of the presence of endosporulation. For species identification, the genotype-specific PCR 18S rDNA assay was used. Thirty-two isolates of Prototheca spp. were found, based on genetic analysis, all isolates were characterized as P. zopfii (genotype 2) being a 450 bp fragment from the internal amplification control and specific amplicon of genotype 2 (165 bp), detectable for all of them. In the tests, resistance to all antibacterial drugs and essential oils, monoterpenes and terpenes with almost absent inhibitory activity, were observed. Among antifungals, amphotericin B (MIC 0,5 to 32 μg/mL; geometric mean: 4,0 μg/mL) and terbinafine (MIC 0,5 to 128 μg/mL; geometric mean: 3,1 μg/mL) were the ones that stood out as well as ketoconazole and itraconazole. Antimicrobial peptides are a new class of drugs with antimicrobial activity, where the highlights were for pexiganan with MIC range from 5,0 to 10 μg/mL, in addition to producing algaecide effect with 5,0 to 20 μg/mL. The MIC produced by h-Lf1-11 was 10 to 80 μg/mL, whereas LL-37 had MIC range from 20 to 80 μg/mL and 40 to 160 μg/mL was the MIC of cecropin B. In general, the results showed the presence of the agent in one of the most important milk-producing regions in Brazil, as well as new drug options against P. zopfii (genotype 2).
publishDate 2021
dc.date.issued.fl_str_mv 2021-03-19
dc.date.accessioned.fl_str_mv 2022-05-05T17:22:28Z
dc.date.available.fl_str_mv 2022-05-05T17:22:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/24291
url http://repositorio.ufsm.br/handle/1/24291
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 600
600
600
600
600
600
600
dc.relation.authority.fl_str_mv 06a1b29c-fde0-4a69-8097-2a9d6a9d9649
fab5fcf3-a5e5-4941-849e-7fa63be0ae7c
bee3850b-1736-40d6-af3c-3ab7d978f802
860bd8db-e3f1-4b8e-bb3e-f1c8f0b14306
9f4b7354-7051-4bdf-a038-0f46d7f9740c
a2383e43-82f7-4794-89eb-3a535a2d43ca
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/24291/1/TES_PPGFARMACOLOGIA_2021_SPEROTTO_VITOR.pdf
http://repositorio.ufsm.br/bitstream/1/24291/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/24291/3/license.txt
bitstream.checksum.fl_str_mv c7c4741024948315802bee089f7164ce
4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1801485282002862080